Our department has gained a reputation in the stereotactic space. Around 40% of our case load is stereotactic treatment, including intracranial and extracranial cases.
Protect the mind
Protect the person
Elekta Esprit, our latest Leksell Gamma Knife, delivers precise automated stereotactic radiosurgery treatments for intracranial targets without compromise
Elekta Esprit is not available in all markets.
Seamlessly integrated system for maximum efficiency
Elekta Esprit provides a complex treatment delivered in a simple and efficient way with its fully integrated system.
Due to few moving parts, the system is highly reliable with
99% uptime*.
The efficiencies allow for a potential patient throughput of >1000 patients/year.
Automated treatment planning
Hear from Dr. DJay Wieczorek, Senior Medical Physicist, Miami Cancer Insitute, how automated planning has created efficiencies in their SRS practice.
Published evidence
Explore the bibliography on health economics and see how the Gamma Knife has impacted other programs
Access the publications
- “Cost-effectiveness analysis of 3 radiation treatment strategies for patients with multiple brain metastases.” Chen, Victor Eric et al. Neuro-oncology practice vol. 10,4 344-351. 23 Nov. 2022, doi:10.1093/nop/npac093
- “Comparing costs of microsurgical resection and stereotactic radiosurgery for vestibular schwannoma.” Schnurman, Zane et al. Journal of neurosurgery, 1-10. 9 Nov. 2018, doi:10.3171/2018.5.JNS18508
- “Long-Term Hearing Outcome After Radiosurgery for Vestibular Schwannoma: A Systematic Review and Meta-Analysis.” Balossier, Anne et al. Neurosurgery vol. 92,6 (2023): 1130-1141. doi:10.1227/neu.0000000000002354
See how Elekta Esprit can improve a program’s reputation and growth
Successful program establishment
Princess Alexandra Hospital, Australia
Successful program establishment
Mary Bird Perkins Cancer Center, USA
We have seen a
clear and unambiguous growth in our SRS
volume beginning almost immediately after we
transitioned our program from LINAC to Gamma Knife
technology.
The added flexibility of the frameless workflow of the
Icon device has further driven program growth through
support for fractionated SRT treatments.
Trends in reimbursement and incidence of SRS procedures compared to open surgery for intracranial targets
Study design
Analysis of Medicare data from 2009 to 2018
Tenfold increase in SRS compared to open surgery over the time period
Reimbursement
Increases in reimbursement for SRS over the time period
The comparison to surgery
Great increase in SRS procedures over the time period while open surgery declined
Book a meeting
Contact us today to learn more about improving patient outcomes and enhancing your clinic's reputation.
Elekta Esprit is not available in all markets.